| SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ... Cell 185 (3), 467-484. e15, 2022 | 965 | 2022 |
| Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre … CD Russell, CJ Fairfield, TM Drake, L Turtle, RA Seaton, DG Wootton, ... The Lancet Microbe 2 (8), e354-e365, 2021 | 323 | 2021 |
| Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study RK Gupta, EM Harrison, A Ho, AB Docherty, SR Knight, M van Smeden, ... The Lancet Respiratory Medicine 9 (4), 349-359, 2021 | 233 | 2021 |
| Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the … CI Bloom, TM Drake, AB Docherty, BJ Lipworth, SL Johnston, ... The Lancet Respiratory Medicine 9 (7), 699-711, 2021 | 178 | 2021 |
| Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study TM Drake, AM Riad, CJ Fairfield, C Egan, SR Knight, R Pius, ... The Lancet 398 (10296), 223-237, 2021 | 159 | 2021 |
| Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK AB Docherty, RH Mulholland, NI Lone, CP Cheyne, D De Angelis, ... The Lancet Respiratory Medicine 9 (7), 773-785, 2021 | 106 | 2021 |
| Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study TM Drake, CJ Fairfield, R Pius, SR Knight, L Norman, M Girvan, ... The Lancet Rheumatology 3 (7), e498-e506, 2021 | 88 | 2021 |
| SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination F Liew, S Talwar, A Cross, BJ Willett, S Scott, N Logan, MK Siggins, ... EBioMedicine 87, 2023 | 85 | 2023 |
| The impact of viral mutations on recognition by SARS-CoV-2 specific T cells TI de Silva, G Liu, BB Lindsey, D Dong, SC Moore, NS Hsu, D Shah, ... Iscience 24 (11), 2021 | 66 | 2021 |
| Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study F Närhi, SR Moonesinghe, SD Shenkin, TM Drake, RH Mulholland, ... The Lancet Digital Health 4 (4), e220-e234, 2022 | 32 | 2022 |
| Pan-viral protection against arboviruses by activating skin macrophages at the inoculation site SR Bryden, M Pingen, DA Lefteri, J Miltenburg, L Delang, S Jacobs, ... Science Translational Medicine 12 (527), eaax2421, 2020 | 31 | 2020 |
| Mosquito saliva enhances virus infection through sialokinin-dependent vascular leakage DA Lefteri, SR Bryden, M Pingen, S Terry, A McCafferty, EF Beswick, ... Proceedings of the National Academy of Sciences 119 (24), e2114309119, 2022 | 28 | 2022 |
| A novel antiviral formulation inhibits a range of enveloped viruses NF Fletcher, LW Meredith, EL Tidswell, SR Bryden, D Gonçalves-Carneiro, ... Journal of General Virology 101 (10), 1090-1102, 2020 | 27 | 2020 |
| Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID‐19 MK Siggins, K Davies, R Fellows, RS Thwaites, JK Baillie, MG Semple, ... Immunology 168 (3), 473-492, 2023 | 21 | 2023 |
| International pediatric COVID-19 severity over the course of the pandemic Y Zhu, FJ Almeida, JK Baillie, AC Bowen, PN Britton, ME Brizuela, ... JAMA pediatrics 177 (10), 1073-1084, 2023 | 16 | 2023 |
| Differences in proteome perturbations caused by the Wolbachia strain wAu suggest multiple mechanisms of Wolbachia-mediated antiviral activity SM Rainey, V Geoghegan, DA Lefteri, TH Ant, J Martinez, CJ McNamara, ... Scientific Reports 13 (1), 11737, 2023 | 8 | 2023 |
| Host inflammatory response to mosquito bites enhances the severity of arbovirus infection CS McKimmie, M Pingen, SR Bryden, DA Lefteri Isbt Science Series 13 (1), 76-79, 2018 | 6 | 2018 |
| Inhibitors of the small membrane (M) protein viroporin prevent zika virus infection E Brown, G Swinscoe, DA Lefteri, R Singh, A Moran, RF Thompson, ... eLife 13, e68404, 2024 | 5 | 2024 |
| Mosquito saliva sialokinin-dependent enhancement of arbovirus infection through endothelial barrier leakage DA Lefteri, SR Bryden, M Pingen, S Terry, EF Beswick, G Georgiev, ... bioRxiv, 2021.02. 19.431961, 2021 | 4 | 2021 |
| Delayed mucosal antiviral responses despite robust peripheral inflammation in fatal COVID-19 JK Sidhu, MK Siggins, F Liew, CD Russell, ASS Uruchurtu, C Davis, ... The Journal of infectious diseases 230 (1), e17-e29, 2024 | 3 | 2024 |
